Skip to content
healthcare.dev

OXCARBAZEPINE

NDC 70377-117, OXCARBAZEPINE, suspension, from Biocon Pharma Inc..

Product NDC
70377-117
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218278
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE60 mg/mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70377-117-11703770117111 BOTTLE in 1 CARTON (70377-117-11) / 250 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/62dfed1d-4c5b-446d-97b3-bad9c33959ff
  • NADAC price for package 70377011711

    GET /v1/drugs/nadac/70377011711

Use it

Look up 70377-117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.